Utama › Obesiti › Georgia › South Fulton
Kajian klinikal Obesiti di South Fulton, GA
12 kajian untuk Obesiti sedang mencari peserta di lokasi dalam dan sekitar South Fulton (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Mengambil pesertaFasa 3
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City · 8 mi jauh
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Mengambil pesertaFasa 3
- AURORA-2 Clinical Site, Union City · 8 mi jauh
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Mengambil pesertaFasa 3
- Privia Medical Group Georgia LLC, Peachtree City · 14 mi jauh
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Mengambil pesertaFasa 3
- AURORA-1 Clinical Site, Union City · 8 mi jauh
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Mengambil pesertaFasa 3
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · 8 mi jauh
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Mengambil pesertaFasa 2
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · 8 mi jauh
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Mengambil pesertaFasa 3
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · 8 mi jauh
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- ACCOMPLISH-2 Research Site, Union City · 8 mi jauh
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
Mengambil pesertaFasa 2
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · 8 mi jauh
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Mengambil pesertaFasa 4
- Southeast Research Specialists, Douglasville · 12 mi jauh
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Mengambil pesertaFasa 3
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City · 8 mi jauh
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Mengambil pesertaFasa 3
- ACCOMPLISH-1 Research Site, Union City · 8 mi jauh
Kajian Obesiti di bandar lain
- Houston, TX43 kajian
- Chicago, IL41 kajian
- New York City, NY40 kajian
- San Antonio, TX40 kajian
- Washington, DC33 kajian
- Orlando, FL32 kajian
- Dallas, TX30 kajian
- Boston, MA28 kajian
- Las Vegas, NV27 kajian
- Miami, FL27 kajian
- Baltimore, MD26 kajian
- Jacksonville, FL25 kajian
Kajian lain di South Fulton
- Berat Badan Berlebihan11 kajian
- Kanser Paru-paru Bukan Sel Kecil8 kajian
- Diabetes Jenis 27 kajian
- Kanser Paru-paru7 kajian
- Kanser Payudara5 kajian
- Leukemia Limfositik Kronik4 kajian
- Kanser Kolorektal4 kajian
- Kegagalan Jantung4 kajian
- Kanser (semua jenis)3 kajian
- Kanser Prostat3 kajian
- Mieloma Pelbagai3 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.